Veneto Tumour Registry, Azienda Zero, Padova, Italy.
Clinical Epidemiology Unit, ISPRO, Florence, Italy.
Gut. 2020 Feb;69(2):311-316. doi: 10.1136/gutjnl-2019-318589. Epub 2019 Apr 30.
The impact of a screening programme on colorectal cancer (CRC) incidence in its target population depends on several variables, including coverage with invitations, participation rate, positivity rate of the screening test, compliance with an invitation to second-level assessment and endoscopists' sensitivity. We propose a synthetic indicator that may account for all the variables influencing the potential impact of a screening programme on CRC incidence.
We defined the 'rate of advanced adenoma on the target population' (AA-TAP) as the rate of patients who received a diagnosis of advanced adenoma within a screening programme, divided by the programme target population. We computed the AA-TAP for the CRC Italian screening programmes (biennial faecal immunochemical test, target population 50-69 year olds) using the data of the Italian National Survey from 2003 to 2016, overall and by region, and assessed the association between AA-TAP and CRC incidence fitting a linear regression between the trend of regional CRC incidence rates in 50-74 year old subjects and the cumulative AA-TAP.
In 2016, the AA-TAP at a national level was 105×100 000, whereas significant differences were observed between the northern and central regions (respectively 126 and 149×100 000) and the South and Islands (36×100 000). The cumulative AA-TAP from 2004 to 2012 was significantly correlated with the difference between CRC incidence rates in 2013-2014 and those in 2003-2004 (p=0.009).
The AA-TAP summarises into a single indicator the potential impact of a screening programme in reducing CRC incidence rates.
筛查计划对目标人群结直肠癌(CRC)发病率的影响取决于多个变量,包括邀请的覆盖率、参与率、筛查试验的阳性率、对二级评估邀请的依从性以及内镜医生的敏感性。我们提出了一个综合指标,可以考虑影响筛查计划对 CRC 发病率潜在影响的所有变量。
我们将“目标人群中高级腺瘤的发生率”(AA-TAP)定义为在筛查计划中诊断为高级腺瘤的患者比例除以计划目标人群。我们使用 2003 年至 2016 年意大利国家调查的数据,计算了 CRC 意大利筛查计划(每两年一次的粪便免疫化学试验,目标人群为 50-69 岁)的 AA-TAP,按地区进行了计算,并评估了 AA-TAP 与 CRC 发病率之间的关联,通过在 50-74 岁人群中区域 CRC 发病率趋势与累积 AA-TAP 之间拟合线性回归来实现。
2016 年,全国范围内的 AA-TAP 为 105×100000,而北部和中部地区(分别为 126 和 149×100000)与南部和岛屿地区(36×100000)之间存在显著差异。2004 年至 2012 年的累积 AA-TAP 与 2013-2014 年和 2003-2004 年 CRC 发病率之间的差异显著相关(p=0.009)。
AA-TAP 将筛查计划在降低 CRC 发病率方面的潜在影响总结为一个单一指标。